Navigation Links
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
Date:7/6/2008

pproximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.

This press release contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's performance, including future performance, products or other events or developments that BD expects to occur or anticipates occurring in the future. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Factors that could cause actual results to vary materially from any forward-looking statement include, but are not limited to: competitive factors; pricing and market share pressures; difficulties inherent in product development and delays in product introductions; changes in regional, national or foreign economic conditions; increases in energy costs and their effect on, among other things, the cost of producing BD's products; fluctuations in costs and availability of raw materials and in BD's ability to maintain favorable supplier arrangements and relationships; changes in healthcare or other governmental regulation; as well as other factors discussed in this press release and in BD's filings with the Securities and Exchange Commission. We do not intend to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by applicable laws or regulations.


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  Cohen, Placitella & Roth, ... investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or ... period from January 31, 2011 through November 2, ... and certain of its officers and directors publically ... of Sections 10(b) and 20(a) of the Securities ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
(Date:11/28/2014)... ARTAS robotic hair transplant surgical procedures ... PAI Medical Group hair transplant surgeons Chris Pawlinga, M.D. ... hair transplant procedure in the Brentwood office on Monday, ... in Tennessee and one of only three medical centers ... robotic hair transplantation. Patients benefit from this minimally invasive, ...
(Date:11/28/2014)... November 28, 2014 This report ... market along with the definite portrayal of the ... point depiction of various variables driving the development ... difficulties blocking the development of the business. ... , According to the report "Worldwide Dental ...
(Date:11/27/2014)... November 28, 2014 As everyone knows, Cyber ... demands of its customers, Tidebuy is now providing ... their favorite products at only 15% of the current prices. ... enjoy the huge savings and free shipping (for orders above ... development of network technology, more and more people are willing ...
(Date:11/27/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... , Firstly, the report provides a basic overview of ... Then, the report explores the international and Chinese major ...
(Date:11/27/2014)... BC (PRWEB) November 27, 2014 ... clinic, has recently announced that its personalized treatment ... treatment techniques can help victims of sports injuries ... shin splints, or patellofemoral pain syndrome, Absolute Physio ... runner’s and jumper’s knee, ACL tears, meniscal injuries, ...
Breaking Medicine News(10 mins):Health News:First in Tennessee - PAI Medical Group Announces ARTAS - The World’s Most Advanced Medical Robot Used for Hair Transplant Surgery 2Health News:Global Dental Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Dental Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Tidebuy.com Launching Overcoats Sales for the Special Monday in 2014 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:Coquitlam Physiotherapy Clinic Now Helps Clients Reach Pre-Injury State 2
... , WEDNESDAY, Aug. 24 (HealthDay News) -- More than ... alive and well, with functioning immune systems, nine years ... report. Most of the patients attend school with ... fatal without treatment. "The promise of gene therapy ...
... Strains of a bacterium commonly found in fruit flies can ... transmitting the virus that causes dengue fever, researchers have found. ... control dengue worldwide. North Carolina State University mathematical biologist ... a research consortium that includes scientists from Australia and the ...
... WEDNESDAY, Aug. 24 (HealthDay News) -- Obesity is costing states ... In nine states, obesity already accounts for 10 percent ... researchers from RTI International, Duke University and the U.S. Agency ... that taxpayers are footing a large part of the bill, ...
... HealthDay Reporter , WEDNESDAY, Aug. 24 (HealthDay News) -- ... shows are more likely to use drugs and alcohol than teens ... The survey included more than 1,000 youths from around the nation ... a typical day, about 70 percent of teens said they used ...
... , WEDNESDAY, Aug. 24 (HealthDay News) -- High doses ... abnormal heart rhythms and should no longer be prescribed ... Wednesday. Doses of Celexa (citalopram hydrobromide) greater than ... electrical activity of the heart, which can lead to ...
... Geneva, 23rd August 2011 The fight against non-communicable diseases ... and liver disease, is at grave risk, because of recent ... Nations negotiations, the European Association for the Study of the ... to Mr Ban Ki-Moon, Dr Margaret Chan and Mr Jose ...
Cached Medicine News:Health News: 'Bubble Boy' Kids Living Normally After Gene Therapy: Study 2Health News: 'Bubble Boy' Kids Living Normally After Gene Therapy: Study 3Health News:Obesity Costing States Billion in Yearly Medical Expenses 2Health News:Teen Drinking, Smoking Higher Among Facebook Users: Survey 2Health News:Teen Drinking, Smoking Higher Among Facebook Users: Survey 3Health News:UN Member States jeopardize international progress on non-communicable disease epidemic 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: